Autonomix Medical Announces 1-for-21 Reverse Stock Split
Autonomix Medical, Inc. announced an amendment to its certificate of incorporation to effect a 1-for-21 reverse stock split of its common stock. The split will become effective at 12:01 am ET on June 24, 2026, with post-split trading commencing the same day on The Nasdaq Capital Market under the existing ticker "AMIX" but with a new CUSIP number. This action will reduce the number of outstanding shares from approximately 11.4 million to about 543,000, while the authorized shares remain at 500 million.
Key Highlights
- Autonomix Medical to effect a 1-for-21 reverse stock split of its common stock.
- The reverse stock split will take effect at 12:01 am ET on June 24, 2026.
- Common stock will trade on a post-split basis on Nasdaq Capital Market starting June 24, 2026, under existing ticker AMIX.
- A new CUSIP number, 05330T304, will be assigned.
- Fractional shares will not be issued; stockholders will receive cash payment in lieu of fractional shares.
- Shares outstanding will reduce from approximately 11.4 million to approximately 543,000.
- The number of authorized shares of common stock will remain at 500 million.
Price Impact
More from AMIX
Autonomix Medical Files 10-K Amendment Detailing Governance and Compensation
Autonomix Medical Gains Scientific Recognition with 13 Abstract Acceptances
Autonomix Medical Discusses Visceral Cancer Pain Treatment